Zambon

Italy - BressoBiotechnology

Website LinkedIn Careers Page

Focus: Small Molecules

Zambon is a life sciences company focused on Small Molecules.

Ophthalmology Cardiovascular

Profile data last refreshed Yesterday

Open Jobs

Data completeness

2/9 — Limited

Company HealthStrong

Pipeline

Late-stage

9 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Products & Portfolio (1)

6 discontinued, 12 duplicate formulations not shown

OLOPATADINE HYDROCHLORIDE

olopatadine hydrochloride

Post-LOE

OPHTHALMIC · SOLUTION/DROPS

1 receptor antagonist. The antihistaminic activity of olopatadine has been documented in isolated tissues, animal models, and humans.

Help build intelligence for Zambon

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis

Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)

N/A

Clinical Trials (1)

NCT06503770A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

N/A

intradermal pholcodine allergy test in cases

Neuromuscular Blocking Agents Anaphylaxis

N/A

Durolane SJ

Rhizarthrosis

N/A

Parkinson's disease nurse specialist care

Parkinson Disease

N/A

Clinical Trials (1)

NCT03830190Cost-effectiveness of Nursing Interventions for Patients With PD

N/A

Vaginal gel, Medical Device Class 2A

Vaginal Dryness

N/A

Clinical Trials (1)

NCT02994342Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness

N/A

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

Parkinson's Disease

N/A

Riluzole 50 mg orodispersible film

Healthy Participants

Phase 1

Clinical Trials (1)

NCT04819438Riluzole Orodispersible Film Replicate Bioavailability

Phase 1

Diclofenac sodium

Healthy

Phase 1

Clinical Trials (1)

NCT02495831Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

Phase 1

Voriconazole inhaled

Allergic Bronchopulmonary Aspergillosis

Phase 1

Clinical Trials (1)

NCT04229303Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Phase 1

Safinamide 50 mg

Healthy

Phase 1

Clinical Trials (1)

NCT03887221A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers

Phase 1

100 mg safinamide

Healthy

Phase 1

Clinical Trials (1)

NCT03216304Safinamide Steady State Interaction With Rosuvastatin

Phase 1

Z7200 without oral activated charcoal

Asthma

Phase 1

Clinical Trials (1)

NCT02631941Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Phase 1

N-acetylcysteine

no Condition

Phase 1

Clinical Trials (1)

NCT02265224Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)

Phase 1

Z7200 without oral activated charcoal

Asthma

Phase 1

Clinical Trials (1)

NCT02237508A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers

Phase 1

N-acetylcysteine

Respiratory Tract Disorders

Phase 1

Clinical Trials (1)

NCT03881163A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers

Phase 1

NAC effervescent tablets

Retinitis Pigmentosa

Phase 1

Clinical Trials (1)

NCT03999021FIGHT-RP 1 Extension Study

Phase 1

Z7200

Asthma

Phase 2

Clinical Trials (1)

NCT02227394Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Phase 2

Oral N-acetycystein

Chronic Bronchitis

Phase 2

Clinical Trials (1)

NCT00205647Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

Phase 2

Safinamide Methanesulfonate

Multiple System Atrophy

Phase 2

Clinical Trials (1)

NCT03753763Safinamide for Multiple System Atrophy (MSA)

Phase 2

Liposomal Cyclosporine A

Bronchiolitis Obliterans Syndrome (BOS)

Phase 2

Clinical Trials (1)

NCT04107675A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)

Phase 2

CMS

Non Cystic Fibrosis Bronchiectasis

Phase 3

Clinical Trials (1)

NCT03460704Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

Phase 3

Liposomal Cyclosporine A 5 mg

Bronchiolitis Obliterans

Phase 3

Clinical Trials (1)

NCT04039347Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)

Phase 3

N-acetylcysteine

Respiratory Tract Diseases

Phase 3

Clinical Trials (1)

NCT03843541A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Phase 3

Safinamide

Parkinson Disease

Phase 3

Clinical Trials (1)

NCT03881371A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Phase 3

CMS

Non Cystic Fibrosis Bronchiectasis

Phase 3

Clinical Trials (1)

NCT03093974Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)

Phase 3

Liposomal Cyclosporine A

Bronchiolitis Obliterans

Phase 3

Clinical Trials (1)

NCT03656926Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)